| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 08-18-2025 | 06-30-2025 | 10-Q | |
| 2 | 05-15-2025 | 03-31-2025 | 10-Q | |
| 3 | 03-28-2025 | 12-31-2024 | 10-K | |
| 4 | 12-23-2024 | 09-30-2024 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
MND combines proprietary resveratrol-based platform and NovaSOL® Curcumin to enhance cognitive performance and support neuropro...
JOTROL™ is currently advancing toward a Phase IIa trial in Parkinson's Disease, following breakthrough preclinical data in ...
PWR delivers science-driven cellular energy and recovery support as part of Jupiter's expanding longevity supplement portfo...
